A Study to Determine the Safety and Sensitizing Potential of HAT1 Topical Products Using Skin Sensitivity Patch Tests

PHASE4CompletedINTERVENTIONAL
Enrollment

182

Participants

Timeline

Start Date

April 1, 2016

Primary Completion Date

June 26, 2016

Study Completion Date

July 21, 2016

Conditions
HealthyAtopic DermatitisPsoriasis
Interventions
DRUG

HAT1

All the participants will have the test product applied to the appropriate test sites by trained study staff. The study was conducted on a mixed population comprising of normal subjects, and patients with atopic dermatitis and active plaque psoriasis.

OTHER

Saline Solution

Only for CIT portion of the study. Participant will have product applied topically on site by the trained study staff.

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Haus Bioceuticals

INDUSTRY

NCT03406117 - A Study to Determine the Safety and Sensitizing Potential of HAT1 Topical Products Using Skin Sensitivity Patch Tests | Biotech Hunter | Biotech Hunter